Romero-Sevilla Raul, Casado-Naranjo Ignacio, Portilla-Cuenca Juan Carlos, Duque-de San Juan Beatriz, Fuentes Jose Manuel, Lopez-Espuela Fidel
Department of Neurology, Hospital San Pedro de Alcantara, Caceres, Spain.
Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED) Madrid, Spain.
Curr Alzheimer Res. 2018;15(7):671-678. doi: 10.2174/1567205015666180119100840.
Evidence of the effect of vascular risk factors and white matter lesions on the progression of mild cognitive impairment (MCI) to dementia is not conclusive.
The study aimed to analyze the impact of these factors on MCI progression to dementia from a global perspective.
Our study included a population of 105 patients with MCI.
After a mean follow-up period of 3.09 years (range, 2-3.79), 47 patients (44.76%) progressed to dementia: 32 (30.8%) to mixed dementia, 13 (12.5%) to probable AD, and 2 (1.9%) to vascular dementia. Total cholesterol levels (OR: 1.015 [1.003-1.028]) and LDL cholesterol levels (OR: 1.018 [1.004-1.032]) increased the risk of progression to dementia. Cystatin C was a protective factor against progression to dementia (OR: 0.119 [0.015-0.944], p = 0.044). During the second year of follow-up, the presence of subcortical white matter hyperintensities increased the risk of progression to dementia (OR: 5.854 [1.008- 33.846]). Subcortical and periventricular white matter hyperintensities were also associated with an increased risk of progression to dementia during the second year of follow-up (OR: 3.130 [1.098-8.922] and OR: 3.561 [1.227-10.334], respectively). The same was true for silent infarcts (OR: 4.308 [1.480- 12.500]).
A high percentage of patients progressed to dementia. Total cholesterol, LDL cholesterol, and white matter hyperintensities were found to be associated with MCI progression to dementia. In contrast, cystatin C was shown to be a protective factor against progression to dementia.
血管危险因素和白质病变对轻度认知障碍(MCI)进展为痴呆症影响的证据尚无定论。
本研究旨在从整体角度分析这些因素对MCI进展为痴呆症的影响。
我们的研究纳入了105例MCI患者。
平均随访3.09年(范围2 - 3.79年)后,47例患者(44.76%)进展为痴呆症:32例(30.8%)进展为混合性痴呆,13例(12.5%)进展为可能的阿尔茨海默病(AD),2例(1.9%)进展为血管性痴呆。总胆固醇水平(比值比:1.015 [1.003 - 1.028])和低密度脂蛋白胆固醇水平(比值比:1.018 [1.004 - 1.032])增加了进展为痴呆症的风险。胱抑素C是预防进展为痴呆症的保护因素(比值比:0.119 [0.015 - 0.944],p = 0.044)。在随访的第二年,皮质下白质高信号的存在增加了进展为痴呆症的风险(比值比:5.854 [1.008 - 33.846])。在随访的第二年,皮质下和脑室周围白质高信号也与进展为痴呆症的风险增加相关(分别为比值比:3.130 [1.098 - 8.922]和比值比:3.561 [1.227 - 10.334])。无症状性梗死情况也是如此(比值比:4.308 [1.480 - 12.500])。
高比例患者进展为痴呆症。发现总胆固醇、低密度脂蛋白胆固醇和白质高信号与MCI进展为痴呆症相关。相反,胱抑素C被证明是预防进展为痴呆症的保护因素。